Thursday 18 April | |
Unilever | Q1 Results |
PZ Cussons | Trading Statement |
D4T4 Solutions | Trading Statement |
Moneysupermarket.com | Q1 Results |
Polymetal International | Q1 Production |
Rentokil Initial | Q1 Results |
Discoverie Group | Trading Statement |
Trifast | Trading Statement |
RWS Holdings | Trading Statement |
Friday 19 April | |
no events scheduled | |
Monday 22 April | |
no events scheduled | |
Tuesday 23 April | |
STV Group | Trading Statement |
Wednesday 24 April | |
Petropavolsk | Full Year Results |
Boohoo Group | Full Year Results |
Puretech Health | Full Year Results |
Maxcyte | Full Year Results |
AB Dynamics | Half Year Results |
Wandisco | Full Year Results |
CRH | Trading Statement |
Associated British Foods | Half Year Results |
Antofagasta | Q1 Production |
Croda International | Q1 Results |
Centamin | Q1 Results |
PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug
(Alliance News) - PureTech Health PLC on Tuesday said that a company it founded and in which it maintains a stake had begun trials of a new treatment for clostridioides difficile infection, in the hopes of moving toward regulatory approval.
Read more